Terms: = Germ cell tumor AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR
115 results:
1. Prognostic Model for High-Grade Neuroendocrine Carcinoma of the Lung Incorporating Genomic Profiling and Poly (ADP-ribose) Polymerase-1 Expression.
Kim HS; Kim JK; Lee JH; Lee YJ; Lee GK; Han JY
JCO Precis Oncol; 2024 Apr; 8():e2300495. PubMed ID: 38635931
[TBL] [Abstract] [Full Text] [Related]
2. CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas.
Tauziède-Espariat A; Nicaise Y; Sievers P; Sahm F; von Deimling A; Guillemot D; Pierron G; Duchesne M; Edjlali M; Dangouloff-Ros V; Boddaert N; Roux A; Dezamis E; Hasty L; Lhermitte B; Hirsch E; Hirsch MPV; Ardellier FD; Karnoub MA; Csanyi M; Maurage CA; Mokhtari K; Bielle F; Rigau V; Roujeau T; Abad M; Klein S; Bernier M; Horodyckid C; Adam C; Brandal P; Niehusmann P; Vannod-Michel Q; Provost C; de Champfleur NM; Nichelli L; Métais A; Mariet C; Chrétien F; Blauwblomme T; Beccaria K; Pallud J; Puget S; Uro-Coste E; Varlet P;
Acta Neuropathol Commun; 2024 Apr; 12(1):55. PubMed ID: 38581034
[TBL] [Abstract] [Full Text] [Related]
3. Sertoli cell-Specific Activation of Transforming Growth Factor Beta Receptor 1 Leads to Testicular Granulosa cell tumor Formation.
Fang X; Nie L; Putluri S; Ni N; Bartholin L; Li Q
Cells; 2023 Nov; 12(23):. PubMed ID: 38067144
[TBL] [Abstract] [Full Text] [Related]
4. foxo1 promotes the expression of canonical WNT target genes in examined basal-like breast and glioblastoma multiforme cancer cells.
Pintor S; Lopez A; Flores D; Lozoya B; Soti B; Pokhrel R; Negrete J; Persans MW; Gilkerson R; Gunn B; Keniry M
FEBS Open Bio; 2023 Nov; 13(11):2108-2123. PubMed ID: 37584250
[TBL] [Abstract] [Full Text] [Related]
5. foxo1-miR-506 axis promotes chemosensitivity to temozolomide and suppresses invasiveness in glioblastoma through a feedback loop of foxo1/miR-506/ETS1/foxo1.
Chen C; Liu Y; Wang H; Zhang X; Shi Y; Chen J
J Zhejiang Univ Sci B; 2023 Aug; 24(8):698-710. PubMed ID: 37551556
[TBL] [Abstract] [Full Text] [Related]
6. Long non-coding RNA SOX2-OT enhances cancer biological traits via sponging to tumor suppressor miR-122-3p and miR-194-5p in non-small cell lung carcinoma.
Dodangeh F; Sadeghi Z; Maleki P; Raheb J
Sci Rep; 2023 Jul; 13(1):12371. PubMed ID: 37524903
[TBL] [Abstract] [Full Text] [Related]
7. Targeting SWI/SNF ATPases in H3.3K27M diffuse intrinsic pontine gliomas.
Mota M; Sweha SR; Pun M; Natarajan SK; Ding Y; Chung C; Hawes D; Yang F; Judkins AR; Samajdar S; Cao X; Xiao L; Parolia A; Chinnaiyan AM; Venneti S
Proc Natl Acad Sci U S A; 2023 May; 120(18):e2221175120. PubMed ID: 37094128
[TBL] [Abstract] [Full Text] [Related]
8. In silico and in vitro analyses of a novel foxo1 agonist reducing Aβ levels via downregulation of BACE1.
Lv MT; Wang HC; Meng XW; Shi YT; Zhang YM; Shan LL; Shi RL; Ni TJ; Duan YC; Yang ZJ; Zhang W
CNS Neurosci Ther; 2024 Mar; 30(3):e14140. PubMed ID: 36892036
[TBL] [Abstract] [Full Text] [Related]
9. The role of EZH2 as a potential therapeutic target in retinoblastoma.
Zhao Y; Cheng Y; Qu Y
Exp Eye Res; 2023 Feb; 227():109389. PubMed ID: 36669714
[TBL] [Abstract] [Full Text] [Related]
10. The foxo1 inhibitor AS1842856 triggers apoptosis in glioblastoma multiforme and basal-like breast cancer cells.
Flores D; Lopez A; Udawant S; Gunn B; Keniry M
FEBS Open Bio; 2023 Feb; 13(2):352-362. PubMed ID: 36602390
[TBL] [Abstract] [Full Text] [Related]
11. Epigenomic and transcriptomic landscaping unraveled candidate repositioned therapeutics for non-functioning pituitary neuroendocrine tumors.
Aydin B; Beklen H; Arga KY; Bayrakli F; Turanli B
J Endocrinol Invest; 2023 Apr; 46(4):727-747. PubMed ID: 36306107
[TBL] [Abstract] [Full Text] [Related]
12. Exosomal miRNA-21 from Toxoplasma gondii-infected microglial cells induces the growth of U87 glioma cells by inhibiting tumor suppressor genes.
Jung BK; Song H; Shin H; Chai JY
Sci Rep; 2022 Sep; 12(1):16450. PubMed ID: 36180486
[TBL] [Abstract] [Full Text] [Related]
13. The miR-183/96/182 cluster is upregulated in glioblastoma carrying EGFR amplification.
Schneider B; William D; Lamp N; Zimpfer A; Henker C; Classen CF; Erbersdobler A
Mol Cell Biochem; 2022 Sep; 477(9):2297-2307. PubMed ID: 35486213
[TBL] [Abstract] [Full Text] [Related]
14. Cytochalasin Q exerts anti-melanoma effect by inhibiting creatine kinase B.
Lu Y; Zhang P; Chen H; Tong Q; Wang J; Li Q; Tian C; Yang J; Li S; Zhang Z; Yuan H; Xiang M
Toxicol Appl Pharmacol; 2022 Apr; 441():115971. PubMed ID: 35276125
[TBL] [Abstract] [Full Text] [Related]
15. Adult Primary Pineal Alveolar Rhabdomyosarcoma with foxo1 Gene Rearrangement and OLIG2 Expression: A Rare Case Report and Literature Review.
Xie L; Wang W; Zhou H; Han Z; Xu J; Xu Z; Xiang J
Int J Surg Pathol; 2022 Oct; 30(7):769-775. PubMed ID: 35188829
[TBL] [Abstract] [Full Text] [Related]
16. Primary Cutaneous Alveolar Rhabdomyosarcoma in an Elderly Adult: A Rare Potential Mimic of Merkel cell Carcinoma.
Lindsey MS; Bridge JA; Douglas DS; Foster JT; Shalin SC; Gardner JM
Am J Dermatopathol; 2022 Mar; 44(3):218-222. PubMed ID: 34991098
[TBL] [Abstract] [Full Text] [Related]
17. PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme cells.
Udawant S; Litif C; Lopez A; Gunn B; Schuenzel E; Keniry M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831287
[TBL] [Abstract] [Full Text] [Related]
18. Inhibition of glioblastoma progression by Urolithin A in vitro and in vivo by regulating Sirt1-foxo1 axis via ERK/AKT signaling pathways.
Liu CL; Zhao D; Li JJ; Liu S; An JJ; Wang D; Hu FA; Qiu CY; Cui MH
Neoplasma; 2022 Jan; 69(1):80-94. PubMed ID: 34818027
[TBL] [Abstract] [Full Text] [Related]
19. XPO1/CRM1 is a promising prognostic indicator for neuroblastoma and represented a therapeutic target by selective inhibitor verdinexor.
Pan L; Cheng C; Duan P; Chen K; Wu Y; Wu Z
J Exp Clin Cancer Res; 2021 Aug; 40(1):255. PubMed ID: 34384466
[TBL] [Abstract] [Full Text] [Related]
20. Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumors.
Sievers P; Henneken SC; Blume C; Sill M; Schrimpf D; Stichel D; Okonechnikov K; Reuss DE; Benzel J; Maaß KK; Kool M; Sturm D; Zheng T; Ghasemi DR; Kohlhof-Meinecke P; Cruz O; Suñol M; Lavarino C; Ruf V; Boldt HB; Pagès M; Pouget C; Schweizer L; Kranendonk MEG; Akhtar N; Bunkowski S; Stadelmann C; Schüller U; Mueller WC; Dohmen H; Acker T; Harter PN; Mawrin C; Beschorner R; Brandner S; Snuderl M; Abdullaev Z; Aldape K; Gilbert MR; Armstrong TS; Ellison DW; Capper D; Ichimura K; Reifenberger G; Grundy RG; Jabado N; Krskova L; Zapotocky M; Vicha A; Varlet P; Wesseling P; Rutkowski S; Korshunov A; Wick W; Pfister SM; Jones DTW; von Deimling A; Pajtler KW; Sahm F
Acta Neuropathol; 2021 Nov; 142(5):827-839. PubMed ID: 34355256
[TBL] [Abstract] [Full Text] [Related]
[Next]
